Funder: European Commission
Due Dates: September 15, 2026 (Full application, ERDERA Phase 2) | September 14, 2026 (Call-level deadline)
Funding Amounts: ~€91.3M total (2026–2027); single grant; 50% funding rate; max €10M per third party for financial support
Summary: Funds the continuation and expansion of the European Partnership on Rare Diseases, advancing EU leadership in rare disease research, data sharing, and healthcare innovation.
Key Information: Only the existing ERDERA consortium (HORIZON-HLTH-2023-DISEASE-07-01) may apply; new partners may be added.